TRIPLE SUBSTITUTED PHENANTHROLINE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE OR HAEMATOLOGICAL DISEASES OR CONDITIONS, OR CANCER
申请人:Medina Padilla Miguel
公开号:US20110306631A1
公开(公告)日:2011-12-15
The present invention relates to a new family of triple substituted phenantroline derivatives of formula (I), which are useful for the treatment or profilaxis of a neurodegenerative or haematological disease or condition or cancer, their use as a medicament, especially for treating a neurodegenerative or haematological disease or condition or cancer, and a pharmaceutical composition comprising the compounds.
本发明涉及一种新的三取代苯并二氮杂菲衍生物家族,其化学式为(I),可用于治疗或预防神经退行性或血液疾病或状况或癌症,它们作为药物的用途,特别是用于治疗神经退行性或血液疾病或状况或癌症,以及包含这些化合物的制药组合物。